Globus Medical IncGMED

NYSEHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$74.27
Market cap
$10.0B
P/E
18.6x
Revenue (TTM)
$3.1B
Net income
$535.4M
Dividend yield
—
1-year total return
34.8%
Net margin
17.0%
Revenue growth
19.7%
Debt / equity
—

What Globus Medical Inc does.

Globus Medical, Inc. (together, as applicable, with its consolidated subsidiaries, “Globus,” the “Company,” “we,” “us” or “our”), headquartered in Audubon, Pennsylvania, is a medical device company that develops and commercializes healthcare solutions whose mission is to improve the quality of life of patients with musculoskeletal disorders. Founded in 2003, Globus is committed to medical device innovation and delivering exceptional service to hospitals, ambulatory surgery centers and physicians to advance patient care and improve efficiency. Since inception, Globus has listened to the voice of the surgeon to develop practical solutions and products to help surgeons effectively treat patients and improve lives.

Globus is an engineering-driven company with a history of rapidly developing and commercializing advanced products and procedures to address treatment challenges. With 9 product launches in 2025 and operations across 65 countries worldwide, we offer a comprehensive portfolio of innovative and differentiated technologies that are used to treat a variety of musculoskeletal conditions. Although we manage our business globally within one reportable segment, we separate our products and services into two major categories: Musculoskeletal Solutions and Enabling Technologies.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$789.0M$958.1M$1.0B$1.6B$2.5B$2.9B
Net income$102.3M$149.2M$190.2M$122.9M$103.0M$537.9M
Free cash flow$135.1M$219.4M$104.4M$165.2M$405.2M$588.8M

More on GMED.

Figures from Globus Medical Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.